...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Investment Banker?

Heck yes!  My biggest fear is that the science gets overlooked because everyone is focusing on management.  Or the lack thereof. 

Share
New Message
Please login to post a reply